CAS No.860005-21-6 Pharmaceutical Intermediates

Introducing LATANOPROSTENE BUNOD, a state-of-the-art pharmaceutical product designed to effectively manage intraocular pressure in patients with glaucoma and ocular hypertension. Our products are known for their high purity, enhanced stability, and proven efficacy. As a factory integrating production and trading, we are committed to providing quality products backed by strict quality control and competitive prices. Choosing LATANOPROSTENE BUNOD is a reliable solution that prioritizes patient safety and treatment effectiveness.

product details

Product details

Product detail

LATANOPROSTENE BUNOD is a novel dual-acting prostaglandin analog that combines the properties of latanoprost and bunod. This innovative formulation is specifically formulated to lower intraocular pressure (IOP) in patients with glaucoma and ocular hypertension. By enhancing aqueous humor outflow and increasing uveoscleral outflow, LATANOPROSTENE BUNOD offers a comprehensive approach to managing IOP, thereby reducing the risk of optic nerve damage and preserving vision.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Physical and Chemical Properties

LATANOPROSTENE BUNOD has a unique molecular structure, which contributes to its effectiveness as a therapeutic agent. The product is a colorless to pale yellow liquid that is soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). Its molecular weight is approximately 507.62 g/mol and its chemical formula is C27H41NO8.

One of the key benefits of LATANOPROSTENE BUNOD is its stability. The product maintains its potency and efficacy over a long shelf life, making it ideal for pharmaceutical formulations. Additionally, LATANOPROSTENE BUNOD is designed to be compatible with a wide range of excipients, thus providing multiple formulation options for eye drop solutions.

Advantages

1. Dual mechanism of action: Latanoprostene BUNOD has a unique dual mechanism of action that effectively reduces intraocular pressure by increasing uveoscleral outflow and enhancing aqueous humor drainage. This combined approach achieves superior intraocular pressure lowering effects compared to traditional therapies.

2. Highly effective: Clinical studies have shown that LATANOPROSTENE BUNOD can significantly reduce intraocular pressure and is one of the most effective drugs for the treatment of glaucoma and ocular hypertension. Its sustained effect can bring long-term benefits to patients and ensure that their condition is optimally managed.

3. Improved Patient Compliance: The formulation of Latanoprostene BUNOD allows for once-daily dosing, thereby improving patient compliance with treatment regimens. This convenience is critical in treating chronic diseases such as glaucoma, where consistent medication use is essential to preserve vision.

4. Good safety: Numerous studies have shown that LATANOPROSTENE BUNOD has a good safety profile with minimal side effects. Common adverse reactions (such as eye congestion and changes in eyelash pigmentation) are generally mild and reversible, making it a safe choice for long-term use.

5. Manufacturing Excellence: As a factory integrating production and trading, we adhere to strict quality control measures throughout the entire manufacturing process. Our state-of-the-art facilities and experienced team ensure that every batch of LATANOPROSTENE BUNOD meets the highest industry standards.

6. Competitive Price: By combining production and trading, we can offer LATANOPROSTENE BUNOD at a competitive price without compromising on quality. This affordable price makes it affordable to a wider range of patients and healthcare providers.

Application

LATANOPROSTENE BUNOD is primarily used to formulate eye drops for the treatment of glaucoma and ocular hypertension. Its versatility enables it to be incorporated into a variety of drug delivery systems, including preservative-free formulations, which is particularly beneficial for patients with sensitive eyes.

In addition to its primary application, ongoing studies are exploring the potential of LATANOPROSTENE BUNOD in other therapeutic areas, such as post-cataract surgery care and the management of other eye diseases.

In summary

In conclusion, LATANOPROSTENE BUNOD is a leading pharmaceutical product that provides a reliable and effective solution for IOP management for patients suffering from glaucoma and ocular hypertension. With its dual mechanism of action, high efficacy, safety and superior manufacturing, our product is expected to make a significant impact in the pharmaceutical industry. Trust LATANOPROSTENE BUNOD for your glaucoma management needs and experience the difference that quality and innovation can make.